Introduction COVID-19 has a wide range of clinical manifestations. Neurological
manifestations in COVID-19 patients were demonstrated during the pandemic, including …

China has the largest population of patients with dementia in the world, imposing a heavy
burden on the public and health care systems. More than 100 epidemiological studies on …

Objective To update the 2001 American Academy of Neurology (AAN) guideline on mild
cognitive impairment (MCI). Methods The guideline panel systematically reviewed MCI …

Background Mild cognitive impairment (MCI) is an intermediate phase between normal
cognitive ageing and overt dementia, with amnesic MCI (aMCI) being the dominant subtype …

Background: Mild cognitive impairment (MCI) induced the majority number of dementia
patients. The prevalence of MCI in China varied across studies with different screening tools …

The aim of this study was to analyze the prevalence of mild cognitive impairment (MCI)
among the aging population (60 years of age and above) in China. Epidemiological …

Background Gut microbiota (GMB) alteration has been reported to influence the Alzheimer's
disease (AD) pathogenesis through immune, endocrine, and metabolic pathways. This study …

Background Epidemiological studies of mild cognitive impairment (MCI) and subtypes of
MCI have rarely focused on rural residents in China. Methods This population‐based study …

Abstract Objective More women have Alzheimer's disease (AD) than men. Understanding
sex differences in mild cognitive impairment (MCI) may further knowledge of AD etiology and …

Neighbourhood built environments have increasingly been recognized as important
nonpharmacological environmental features that contribute to cognitive health. However …